2009
DOI: 10.1080/13880200802437008
|View full text |Cite
|
Sign up to set email alerts
|

Anticonvulsant effects ofCalotropis proceraroot in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
20
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 18 publications
0
20
0
Order By: Relevance
“…16 It also has antiinflammatory and anticonvulsant actions. 17,18 The root extract inhibited both pentylenetetrazole and maximal electroshock seizures. Hepatoprotective effect has been exhibited by flowers.…”
mentioning
confidence: 99%
“…16 It also has antiinflammatory and anticonvulsant actions. 17,18 The root extract inhibited both pentylenetetrazole and maximal electroshock seizures. Hepatoprotective effect has been exhibited by flowers.…”
mentioning
confidence: 99%
“…While, Calotoxin has GLIDE score of -11.23 and bond strength of -2.51 Å ( Figure 1B and 4), also Quercetin-3-rutinoside has GLIDE score of -11.21 and bond strength of -0.66 Å showed interaction comparable with Aricept-AChE complex. This binding study may predict mode of action and active chemical moiety from Calotropis procera latex responsible for AChE inhibition and its claim to possesses anti-amnesic 14 , anti-convulsant 15 and neuroprotective effects. 16 Among the selected compounds from seeds of Brassica campestris, Vitamin A showed GLIDE score -11.02 and bond strength -5.54 Å (Figure 2A and 4) while Glucobrassicin (Glucosinolate) has GLIDE score of -10.85 and bond strength of -4.0 Å ( Figure 2B and 4) which denotes tight binding and high energies when compared with Aricept-AChE complex.…”
Section: Resultsmentioning
confidence: 99%
“…The incidence and prevalence of epilepsy varies with age (Banerjee et al, 2009) and is highest among children below 7 years of age and in individuals of above 55 years (Jalalpure et al, 2009). In India, the prevalence of epilepsy is about 5.5 to 7.9 per 1000 people, which is about 1/18th of the world population (Nag, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Effectiveness of these drugs does not hold true with the entire range of population suffering from this disorder and they are unable to control epileptic seizures in as many as 25% of patients (Jalalpure et al, 2009). In developing countries the treatment of epilepsy is inaccessible and unaffordable (Ojewole, 2008).…”
Section: Introductionmentioning
confidence: 99%